SCHEMBL6811648

SCHEMBL6811648

CC(c1ccsc1)n1c(N)nc2[nH]cnc2c1=O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 1/20 0.33
▸ ALOX5 P09917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27335385 0.81 PNP (0.35) KDM5B
SCHEMBL17186400 0.79 SIGMAR1 (0.35) KDM5BALOX5
SCHEMBL5021599 0.78 ADORA2B (0.43) —
Hydrochloric Acid SCHEMBL17186284 0.78 SIGMAR1 (0.35) KDM5BALOX5
SCHEMBL9806961 0.77 ADORA2B (0.36) —
SCHEMBL441795 0.76 ADORA2B (0.35) —
SCHEMBL6751928 0.76 ADORA2B (0.35) —
SCHEMBL17186445 0.75 OGA (0.45) —
Hydrochloric Acid SCHEMBL18605853 0.74 OGA (0.44) —
SCHEMBL4964555 0.71 PNP (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0702683-B8 06-SUBSTITUTED GUANINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE IN TREATING TUMOUR CELLS CANCER REC TECH LTD (GB) 2004-09-08 — — EP disclosed
EP-0702683-A1 06-SUBSTITUTED GUANINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE IN TREATING TUMOUR CELLS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-03-27 — — EP disclosed
Send feedback